glp 1 and alcohol GLP-1s Hold Promise as Treatment for Use Disorder GLP-1 Therapeutics and Their Emerging
Description
Correale et al., 2021)
Olsen MB, Hvelmann U, Griffin J, Knudsen KM, Eriksson P-O, Agersnap MA
The semaglutide group were significantly less likely to experience MACE
The efficacy of IDegLira (Insulin Degludec/Liraglutide combination) in adults with type 2 diabetes inadequately controlled with a GLP-1 receptor agonist and oral therapy: DUAL III randomized clinical trial
Jiang W, Wang Q, Zhang X, Yang H, Yang X
